Current knowledge about mechanisms of drug resistance against ALK inhibitors in non-small cell lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers, 13, 4, S. 699-
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2021
- Ereignis
-
Veröffentlichung
- (wer)
-
MDPI AG
- (wann)
-
2021
- Urheber
- DOI
-
10.3390/cancers13040699
- URN
-
urn:nbn:de:bvb:384-opus4-1016426
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smolle, Elisabeth
- Taucher, Valentin
- Lindenmann, Joerg
- Jost, Philipp J.
- Pichler, Martin
- Universität Augsburg
- MDPI AG
Entstanden
- 2021
Ähnliche Objekte (12)
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
The role of microRNAs in breast cancer stem cells
The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases
MicroRNAs, genomic instability and cancer
Involvement of long non-coding RNAs in glucose metabolism in cancer
Non-coding RNAs and SARS-related coronaviruses
MicroRNAs: clinical relevance in colorectal cancer
MicroRNAs as theranostics targets in oral carcinoma stem cells
Prediction of postoperative clinical outcomes in resected stage I non-small cell Lung cancer focusing on the preoperative glasgow prognostic score
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
The role of microRNAs in breast cancer stem cells
The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases
MicroRNAs, genomic instability and cancer
Involvement of long non-coding RNAs in glucose metabolism in cancer
Non-coding RNAs and SARS-related coronaviruses
MicroRNAs: clinical relevance in colorectal cancer
MicroRNAs as theranostics targets in oral carcinoma stem cells
Prediction of postoperative clinical outcomes in resected stage I non-small cell Lung cancer focusing on the preoperative glasgow prognostic score
Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition
The biological and clinical relevance of Inhibitor of Growth (ING) genes in non-small cell lung cancer
RNA-binding proteins as important regulators of long non-coding RNAs in cancer
The role of microRNAs in breast cancer stem cells
The prognostic long-term impact of chronic obstructive pulmonary disease and postoperative mucostasis in patients with curatively resected non-small cell lung cancer
The implications of the long non-coding RNA NEAT1 in non-cancerous diseases
MicroRNAs, genomic instability and cancer
Involvement of long non-coding RNAs in glucose metabolism in cancer
Non-coding RNAs and SARS-related coronaviruses
MicroRNAs: clinical relevance in colorectal cancer
MicroRNAs as theranostics targets in oral carcinoma stem cells